1. Evaluating the Science of Cardiogenic Shock

3. Introduction

4. Coordination of Care for Cardiogenic Shock Team Approach

5. Potential Cardiogenic Shock Care Pathway, Location and Providers

6. Cardiogenic Shock Care Multidisciplinary Team

7. Elements of Cardiogenic Shock Team

8. Ensuring Patients Are Referred or Seen at the Right Time

9. Cardiogenic Shock Center Characteristics 2017 AHA Scientific Statement

10. Trends in MCS Use and Hospital Mortality

11. IABP-SHOCK II Trial

12. Role of Temporary MCS Patient and Programmatic Considerations

13. Clinical Considerations for Device Selection Short-Term MCS

14. Recent Meta-Analyses

15. Need for Randomized Controlled Data

16. Recommendation for IABP Use US vs European Guidelines

17. Relevant Guidelines for Non-AMI Cardiogenic Shock

18. Management of AMI in ST-Segment Elevation 2017 ESC European Guidelines

19. Management of ST-Elevation MI US Guideline: 2013 ACCF/AHA

20. Importance of Early Recognition and Stabilization

21. Outcomes in Cardiogenic Shock IMPRESS Trial, CULPRIT-SHOCK Trial

22. Refractory VF/VT Out-of-Hospital Cardiac Arrest Critical Care Strategies and Outcomes

23. Key Considerations

24. Patient Characteristics and Impact of Timing of IABP Retrospective Analysis

25. Summary

26. Abbreviations

27. Abbreviations (cont)

28. Abbreviations (cont)